Impact of Replacing Fentanyl With Hydromorphone as the First-Line Postoperative Opioid Among Patients Undergoing Outpatient Cancer Surgery
CONCLUSIONS: The multidisciplinary team concluded that the increase in postoperative length of stay associated with hydromorphone was not clinically significant and the decrease waste of prefilled syringes outweighed the small potential increased risk of resurgery compared to the shorter-acting fentanyl. We will therefore use hydromorphone moving forward.PMID:38493405 | DOI:10.1016/j.jopan.2023.11.007
Source: Journal of Perianesthesia Nursing - Category: Nursing Authors: Jennifer R Majumdar John Grbic Sigrid Carlsson Donna Barreiro Marie Marte Vincent Laudone Melissa J Assel Geema Masson Source Type: research
More News: Anesthesia | Anesthesiology | Cancer | Cancer & Oncology | Fentanyl | Nurses | Nursing | Statistics | Study